Download full announcement Utah issues CLIA Certificate of Registration to allow patient testing New laboratory enables five-fold test volume increase to support 2020 commercial goals Renalytix AI plc (LSE: RENX),... read more →
Download full announcement US National pricing of $950 effective as of January 1st, 2020 Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that it is participating in a London based event focused on... read more →
Download full announcement Effective October 16, KidneyIntelX will be covered for reimbursement for qualified members Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease,... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces the appointment of leading kidney investigator and clinician Dr. Chirag Parikh... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that CPT reimbursement code 0105U for its KidneyIntelX™ test has... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that it expects to appoint an additional non-executive director and... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Centers for Medicare & Medicaid Services (“CMS”) has published... read more →
Download full announcement RenalytixAI Expands Leadership Team with Focus on Reimbursement ahead of roll-out of artificial intelligence clinical in vitro diagnostic KidneyIntelX ™ RenalytixAI plc (AIM: RENX), a developer of... read more →
Download full announcement Renalytix AI welcomes US Administration’s dedication to advancing American kidney health Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease,... read more →